Metraipolis › archive › dc_7b199df4c102
Characterization of the safety notes of pharmaceutical products issued by two regulatory authorities from Latin America — Europe PMC PMID:42531586
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42531586
- DOI
- 10.17843/rpmesp.2026.432.15489
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T16:53:25.948Z
- SHA-256 of the archived text
6479f76827b0f253b97e292b7f09c097110b067dcd519199eb4ac9de3c6a05d0- Stable URL of this page
https://metraipolis.com/documento/dc_7b199df4c102
How to cite
Characterization of the safety notes of pharmaceutical products issued by two regulatory authorities from Latin America — Europe PMC PMID:42531586 — Europe PMC (en), https://europepmc.org/article/MED/42531586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b199df4c102 (Metraipolis archive dc_7b199df4c102, sha256 6479f76827b0f253b97e292b7f09c097110b067dcd519199eb4ac9de3c6a05d0)
BibTeX
@misc{dc7b199df4c102,
title = {Characterization of the safety notes of pharmaceutical products issued by two regulatory authorities from Latin America — Europe PMC PMID:42531586},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42531586},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b199df4c102; sha256 6479f76827b0f253b97e292b7f09c097110b067dcd519199eb4ac9de3c6a05d0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42531586. Agents can read the archived copy with the MCP tool read_document.